1 / 3

1. Immunosuppressant Medications Calcineurin Inhibitors (CNI) Prograf / Tacrolimus / Hecoria

Common Medications in Abdominal Transplantation. Post-Transplant Complications. Post-Transplant Care/Management. 1. Visit Frequency Months 1 , 3 , 12, annually and prn Laboratory Frequency SEE CHART on OTHER SIDE Protocol Kidney Biopsy Schedule Month 3, 12 and 24 and prn

nichole-lucas
Download Presentation

1. Immunosuppressant Medications Calcineurin Inhibitors (CNI) Prograf / Tacrolimus / Hecoria

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Common Medications in Abdominal Transplantation Post-Transplant Complications Post-Transplant Care/Management • 1. Visit Frequency • Months 1, 3, 12, annually and prn • Laboratory Frequency • SEE CHART on OTHER SIDE • Protocol Kidney Biopsy Schedule • Month 3, 12 and 24 and prn • Hepatitis B chronic/carrier states • Pre-transplant patients must be evaluated and cleared by hepatologist at NMH • Carriers will be placed on treatment at the time of transplant pending hepatology recommendations • Chronic or carrier HBV patients should remain on treatment after transplant and follow-up with NMH transplant hepatology • Health Maintenance Schedule • Vaccinations • No live vaccines • Annual seasonal influenza • Pneumonia vaccine q5 years • Hepatitis A and B if not immune • Hepatitis B high-dose (40mg) day 0, 7, 28 • Colonoscopy –per ACS guidelines • Pap Smear/HPV testing –annually • Mammogram—per ACS guidelines • Annually (with risk assessment) • Lipids • Q6-12 months • f. Dermatology screening • i. Annually • 1. Immunosuppressant Medications • Calcineurin Inhibitors (CNI) • Prograf/Tacrolimus/Hecoria • Neoral/Cyclosporine/Gengraf • b. mTor Inhibitors • Rapamune/Sirolimus • Zortress/Everolimus • Prednisone • Anti-proliferative medications • Myfortic/Mycophenolic acid (enteric coated) • Cellcept/Mycophenolatemofetil • Imuran/Azathioprine • Infection Prophylaxis Medications • PCP Prophylaxis • Bactrim SS/SMTZ SS QD • After one year can be changed to TIW • OR • ii. Mepron/Atovaquon (sulfa allergy) – stopped after one year • CMV prophylaxis – Valcyte 450 mg poqd x 6 months (if D-/R-then acyclovir) • Anti-fungal—Mycelex troche bid x 3 mos • Common Calcineurin Inhibitor Drug Interactions* • Azole anti-fungals • Protease inhibitors • Grapefruit • Erthromycin/Macrolides • Diltiazem/Verapamil • Statins will require lower starting dose • CYP450 medications can alter CNI levels • * Not an exhaustive list • 1. Surgical Complications • Vascular • Stenosis –can be managed by interventional radiology or surgical intervention if necessary—should be done at NMH preferably • b. Wound—Dehiscence and infections most common in the first three months—more prevalent in diabetics, obese population. • Fluid Collections—require fluid analysis • Urinoma • Lymphocele • Seroma • Medical Complications • Hypertension • Hyperlipidemia • Chronic kidney disease • Malignancies • Anemia • Leukopenia • Infectious Complications • Pneumocystis pneumonia • Cytomegalovirus • Fungal • BK virus • Varicella zoster • Urinary tract infections Reference: American Society of Transplantation, Guidelines for Post-Kidney Transplant Management in the Community Setting, 2009

  2. Kidney, Kidney/Pancreas and Pancreas Alone Transplant Standard of Care (SOC) Labs Urine Dip to include: Protein, leukocytes, nitrites, protein, blood, glucose, blood; Reflex testing for Protein trace or >: order random urine protein and creatinine; Reflex testing for Leukocyte and/or nitrate positive: Order urine C&S +pancreas patients only; *only those child-bearing females (ages up to 60) on Myfortic, Cellcept, mycophenolatemofetil or mycophenolic acid; ^for patients who are HBsAg+ or HBcAb+

  3. The Timeline of Post-Transplant Infections Modified from 1-3 Donor- Derived NOSOCOMIAL TECHNICAL DONOR/RECIPIENT Activation of Latent Infections, Relapsed, Residual, Opportunistic Infections COMMUNITY ACQUIRED TRANSPLANTATION DYNAMIC ASSESSMENT OF INFECTIOUS RISK Recipient- Derived < 4 WEEKS 1-6 MONTHS > 6 MONTHS Common Infections in Solid Organ Transplantation Recipients

More Related